ASTRAZENCA'S COVID-19 vaccine candidate (ChAdOx1-S) has moved a step closer to gaining provisional registration, after the Therapeutic Goods Administration (TGA) granted a provisional determination in relation to it on Fri.
The provisional determination paves the way for the vaccine to be registered on the Australian Register of Therapeutic Goods (ARTG).
"Normally for a vaccine to be registered in Australia, a sponsor (usually a pharmaceutical company) is required to submit a complete and comprehensive package of data to the TGA," the TGA said.
"A formal evaluation is then carried out in multiple stages by technical experts, prior to a decision being made.
"The provisional pathway provides a formal and transparent mechanism for speeding up the registration of promising new medicines with preliminary clinical data. In order to apply for provisional registration, the sponsor must first apply for a provisional determination.
"Further information on eligibility criteria can be found at: Provisional determination: A step-by-step guide for prescription medicines.
"In making its decision to grant AstraZeneca a provisional determination, the TGA considered all eligibility criteria, including factors such as the evidence of a plan to submit comprehensive clinical data and the seriousness of the current COVID-19 pandemic.
"In addition to this determination, the TGA is actively monitoring COVID-19 vaccine development that is occurring both in Australia and around the world, and is part of a network of international regulators that meet regularly to discuss the development of COVID-19 vaccines and the establishment of systems for monitoring the efficacy and safety of COVID-19 vaccines once they have reached the market.
"The ability to access early data and planned collaboration with international regulators will assist the TGA to expedite the evaluation of any new vaccines without compromising on our strict requirements for safety, quality and effectiveness of products."
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Oct 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Oct 20
